No clinical factors, including age, sex, HBsAg status, microvascular invasion, tumor size, cirrhosis status, histological grade, AFP level, tumor encapsulation status and early recurrence status, were significantly associated with the upregulation of ZEB1 expression in HCC (Table 1). This evidence concerns the gene AFP and hepatocellular carcinoma.